胺缺乏和神经炎症是导致酒精使用障碍的重要因素
Nikhila Kalapatapu1, Samantha G Skinner2, Emma G D'Addezio2
1Institute for Addiction Science, University of Southern California, Los Angeles, CA 90033, USA.
概括
目前的酒精使用障碍 (AUD) 治疗由于乙醇的全身影响而不足. 这篇评论强调了胺缺乏和神经炎症是AUD进展的关键,未被强调的机制.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 酒精使用障碍 (AUD) 呈现出显著的发病率,但目前FDA批准的治疗方法提供有限的疗效.
- 乙醇 (EtOH) 具有复杂的系统性作用,特别影响肠-肝-脑轴.
- 关键的AUD进展机制,胺缺乏和神经炎症,在治疗开发中未被强调.
研究的目的:
- 审查AUD的全身机制,重点关注胺缺乏和神经炎症.
- 为了突出胺缺乏和EtOH诱导的神经炎症之间的新兴联系.
- 讨论AUD的潜在治疗目标,以解决这些系统性病理机制.
主要方法:
- 文献综述专注于酒精使用障碍的病理机制.
- 对胺缺乏和神经炎症在AUD中的作用的分析.
- 探索连接这两个机制的新兴研究.
主要成果:
- 酒精诱导的胺缺乏会损害代谢酶,导致能量缺乏和氧化应激.
- 乙醇激活TLR4和NLRP3,这是神经免疫反应的关键调节者.
- 新出现的证据表明,在AUD中,胺缺乏和神经炎症之间存在联系.
结论:
- 胺缺乏和神经炎症是AUD进展中的关键,相互关联的病理机制.
- 解决这些系统性问题为新的治疗策略提供了潜力.
- 需要进一步的研究,以充分阐明在AUD中胺缺乏和神经炎症之间的关系.
关键词:
在 AUD 中,AUD 是 AUD.在NLRP3中,NLRP3是NLRP3中的一个.在TLR4中,酒精 酒精 酒精 酒精 酒精 酒精 酒精肠 - 肝 - 大脑轴神经炎症是一种神经炎症.胺胺的使用方法更多相关视频
09:26Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
18.9K
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
8.5K
相关概念视频
CNS Depressants: Alcohol and Nicotine
362
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
362
Role of Neurotransmitters in Memory
996
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
996
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Disorders of the Nervous Tissue
1.6K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.6K
